Management of Recurrent Patellar Infection
For recurrent patellar infection, you must first determine if this is a prosthetic joint infection (PJI) or a fracture-related infection (FRI), as management differs fundamentally between these two scenarios.
Initial Diagnostic Workup
Obtain these specific tests to establish infection and guide treatment 1:
- Serum markers: ESR and CRP (combination provides best sensitivity/specificity)
- Arthrocentesis (if prosthetic joint): Synovial fluid for cell count with differential and aerobic/anaerobic cultures
- Withhold antibiotics for ≥2 weeks before obtaining cultures if patient is medically stable 1
- Blood cultures if fever present or acute symptom onset 1
- Consider metagenomic next-generation sequencing - demonstrates 93.8% sensitivity versus 53.1% for traditional culture in patellar FRI 2
Management Algorithm Based on Infection Type
If Prosthetic Joint Infection (Patellar Component)
For recurrent PJI, repeat two-stage exchange is the primary treatment approach 1, 3:
Resection arthroplasty with spacer placement:
- Remove all prosthetic components
- Insert antimicrobial-impregnated cement spacer
- Obtain intraoperative tissue cultures (≥3-5 samples)
Antimicrobial therapy duration 1:
- 2-6 weeks IV pathogen-specific therapy
- For staphylococcal infections: rifampin 300-450mg PO BID combined with IV therapy, then transition to rifampin plus oral companion drug (ciprofloxacin or levofloxacin preferred) for 6 months total for knee/patellar infections
- If rifampin cannot be used: 4-6 weeks IV therapy alone
Reimplantation timing 1:
- Delayed reimplantation after 4-6 weeks IV antibiotics PLUS 2-8 week antibiotic-free period (most successful approach in US)
- Check ESR/CRP before reimplantation to assess treatment success
- Earlier reimplantation (2-6 weeks) acceptable if not MRSA, enterococci, or multidrug-resistant gram-negatives
Critical pitfall: Recurrent PJI has substantially worse outcomes than primary revision 3. If multiple treatment failures occur, consider definitive options: chronic antibiotic suppression, arthrodesis, resection arthroplasty, or amputation.
If Fracture-Related Infection (Post-Fixation)
Management depends on timing and fracture stability 2, 4:
Early infection (<2 weeks) or acute onset with stable fixation 4:
- DAIR approach (Debridement, Antibiotics, Implant Retention)
- Requires stable construct and adequate soft tissue coverage
- Success rate reasonable if these criteria met
Late infection (>2 weeks) or unstable fixation 2, 4:
- Radical debridement with hardware removal if fracture healed
- Hardware exchange if fracture not yet united (15/32 patients in one series)
- Apply negative pressure wound therapy (NPWT) for 5-10 days post-debridement 5
- Flap coverage for definitive soft tissue reconstruction after infection control 5
Septic arthritis involvement (occurred in 7/32 patients) 2:
- Arthroscopic knee lavage in addition to above measures
- Continuous normal saline irrigation during NPWT phase
Salvage option for complex recurrent cases 4:
- Total patellectomy - acceptable functional results reported
- Reserve for cases with inadequate soft tissue, persistent infection, or multiple failed attempts
Specific Considerations for Recurrence
- Diabetes mellitus (OR 1.89 for infection after patellar tendon repair)
- Compromised soft tissues from prior surgeries
- Inadequate initial debridement
- Persistent biofilm on retained hardware
Antibiotic selection must target identified organism - metagenomic sequencing significantly outperforms culture (93.8% vs 53.1% sensitivity) 2, particularly valuable in culture-negative recurrent infections.
Expected outcomes: All 32 patients with patellar FRI in the most recent series achieved union with 100% excellent/good functional scores using comprehensive management 2, but this requires meticulous technique and often multiple procedures. Recurrent PJI outcomes remain inferior to primary revision 3.